Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloproteinases in immunity

E J Goetzl1, M J Banda, D Leppert

  • 1Department of Medicine, University of California, San Francisco 94143, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity.

Journal of internal medicine·2021
Same author

Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis.

European journal of neurology·2020
Same author

'Progressive MS - macro views': The need for novel clinical trial paradigms to enable drug development for progressive MS.

Multiple sclerosis (Houndmills, Basingstoke, England)·2017
Same author

Composite end points to assess delay of disability progression by MS treatments.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Clinical and experimental immunology·2012
Same author

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.

Neurology·2011

Matrix metalloproteinases (MMPs) are enzymes crucial in tissue remodeling. This study highlights their roles in immune responses and suggests MMP inhibitors may treat autoimmune diseases.

Area of Science:

  • Immunology
  • Biochemistry
  • Cell Biology

Background:

  • Matrix metalloproteinases (MMPs) are a diverse family of zinc-dependent endopeptidases.
  • MMPs play roles in extracellular matrix degradation and tissue remodeling.
  • Immune cells, including macrophages and T cells, produce and secrete various MMPs.

Purpose of the Study:

  • To elucidate the specific roles of MMPs secreted by macrophages and T cells in immune responses.
  • To investigate the regulation of MMP production by immune cell interactions and cytokines.
  • To explore the potential therapeutic applications of MMP inhibitors in autoimmune diseases.

Main Methods:

  • Analysis of MMP production and secretion by macrophages and T cells.
  • Investigation of regulatory mechanisms involving cell surface molecules (e.g., integrins, VCAM-1) and cytokines.

Related Experiment Videos

  • Evaluation of MMP activity in animal models of autoimmunity.

    • Main Results:

    • T cells primarily secrete gelatinases (MMP-2, MMP-9) upon stimulation.
    • Macrophage-derived MMPs contribute to connective tissue degradation and growth factor release.
    • MMPs from both cell types facilitate TNF-alpha secretion.
    • MMP inhibitors demonstrated therapeutic potential by reducing edema and inflammation in animal models.

    Conclusions:

    • MMPs are critical mediators in immune cell function, tissue remodeling, and inflammatory processes.
    • Targeting MMPs with inhibitors shows promise for managing autoimmune conditions and associated tissue damage.